These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33815420)

  • 1. Allograft or Recipient ST2 Deficiency Oppositely Affected Cardiac Allograft Vasculopathy
    Zhang Z; Zhang N; Shi J; Dai C; Wu S; Jiao M; Tang X; Liu Y; Li X; Xu Y; Tan Z; Gong F; Zheng F
    Front Immunol; 2021; 12():657803. PubMed ID: 33815420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental cardiac allograft vasculopathy in mice.
    Ardehali A; Billingsley A; Laks H; Drinkwater DC; Sorensen TJ; Drake TA
    J Heart Lung Transplant; 1993; 12(5):730-5. PubMed ID: 8241210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basophils Trigger Fibroblast Activation in Cardiac Allograft Fibrosis Development.
    Schiechl G; Hermann FJ; Rodriguez Gomez M; Kutzi S; Schmidbauer K; Talke Y; Neumayer S; Goebel N; Renner K; Brühl H; Karasuyama H; Obata-Ninomiya K; Utpatel K; Evert M; Hirt SW; Geissler EK; Fichtner-Feigl S; Mack M
    Am J Transplant; 2016 Sep; 16(9):2574-88. PubMed ID: 26932231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic rejection in H-2 matched cardiac allografts: early emergence of vasculopathy, alloantibody, and accumulation of IFN-gamma and IL-10 mRNA.
    Zhang QW; Tomita Y; Matsuzaki G; Uchida T; Yoshikawa M; Nakashima Y; Sueishi K; Nomoto K; Yasui H
    Transpl Int; 2001 Jun; 14(3):143-52. PubMed ID: 11499903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinol suppresses cardiac allograft rejection in a murine model.
    Lu C; Zeng YQ; Liu H; Xie Q; Xu S; Tu K; Dou C; Dai Z
    J Heart Lung Transplant; 2017 Feb; 36(2):227-236. PubMed ID: 27574736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection and cardiac allograft vasculopathy.
    Koskinen PK; Kallio EA; Tikkanen JM; Sihvola RK; Häyry PJ; Lemström KB
    Transpl Infect Dis; 1999 Jun; 1(2):115-26. PubMed ID: 11428979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of Smad3 improves cardiac allograft rejection in mice.
    Wang YY; Jiang H; Wang YC; Huang XR; Pan J; Yang C; Shou ZF; Xiang SL; Chen DJ; Lan HY; Chen JH
    Oncotarget; 2015 Jul; 6(19):17016-30. PubMed ID: 26219259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular HMGB1 Contributes to the Chronic Cardiac Allograft Vasculopathy/Fibrosis by Modulating TGF-β1 Signaling.
    Zou H; Ming B; Li J; Xiao Y; Lai L; Gao M; Xu Y; Tan Z; Gong F; Zheng F
    Front Immunol; 2021; 12():641973. PubMed ID: 33777037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
    Soleimani B; Fu F; Lake P; Shi VC
    J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of tolerance induction and prevention of cardiac allograft vasculopathy in miniature swine: the effect of augmentation of donor antigen load.
    Yamada K; Mawulawde K; Menard MT; Shimizu A; Aretz HT; Choo JK; Allison KS; Slisz JK; Sachs DH; Madsen JC
    J Thorac Cardiovasc Surg; 2000 Apr; 119(4 Pt 1):709-19. PubMed ID: 10733759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockout of microRNA-155 ameliorates the Th1/Th17 immune response and tissue injury in chronic rejection.
    Zhang A; Wang K; Zhou C; Gan Z; Ma D; Ye P; Sun Y; Wu J; Huang X; Ren L; Deng P; Wu C; Yue Z; Ding X; Chen J; Xia J
    J Heart Lung Transplant; 2017 Feb; 36(2):175-184. PubMed ID: 27296836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 21 (IL-21) regulates chronic allograft vasculopathy (CAV) in murine heart allograft rejection.
    Khattar M; Baum CE; Schroder P; Breidenbach JD; Haller ST; Chen W; Stepkowski S
    PLoS One; 2019; 14(11):e0225624. PubMed ID: 31756235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.
    Zhao DX; Hu Y; Miller GG; Luster AD; Mitchell RN; Libby P
    J Immunol; 2002 Aug; 169(3):1556-60. PubMed ID: 12133984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early and late chemokine production correlates with cellular recruitment in cardiac allograft vasculopathy.
    Yun JJ; Fischbein MP; Laks H; Fishbein MC; Espejo ML; Ebrahimi K; Irie Y; Berliner J; Ardehali A
    Transplantation; 2000 Jun; 69(12):2515-24. PubMed ID: 10910271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-Like Receptor 4 Deficiency Improves Short-term Renal Function but not Long-term Graft Survival in a Fully MHC-Mismatched Murine Model of Renal Allograft Transplantation.
    Kwan TK; Chadban SJ; Wu H
    Transplantation; 2016 Jun; 100(6):1219-27. PubMed ID: 27077596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term cardiac allograft survival across an MHC mismatch after "pruning" of alloreactive CD4 T cells.
    Hu M; Watson D; Zhang GY; Graf N; Wang YM; Sartor M; Howden B; Fletcher J; Alexander SI
    J Immunol; 2008 May; 180(10):6593-603. PubMed ID: 18453578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
    Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
    Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide, a Glucagon-like Peptide-1 Receptor Agonist, Attenuates Development of Cardiac Allograft Vasculopathy in a Murine Heart Transplant Model.
    Wang Z; Wang M; Hu X; Li Y; Ma D; Li S; Zhao G; Xie Y; Shu Y; Yang J
    Transplantation; 2019 Mar; 103(3):502-511. PubMed ID: 30211824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the development of cardiac allograft vasculopathy.
    Seki A; Fishbein MC
    Cardiovasc Pathol; 2014; 23(5):253-60. PubMed ID: 24972526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.